000 01457 a2200469 4500
005 20250517083412.0
264 0 _c20180411
008 201804s 0 0 eng d
022 _a1365-2990
024 7 _a10.1111/nan.12320
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBurel-Vandenbos, F
245 0 0 _aMET immunolabelling is a useful predictive tool for MET gene amplification in glioblastoma.
_h[electronic resource]
260 _bNeuropathology and applied neurobiology
_cApr 2017
300 _a252-266 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aBiomarkers, Tumor
_xanalysis
650 0 4 _aBrain Neoplasms
_xgenetics
650 0 4 _aCohort Studies
650 0 4 _aFemale
650 0 4 _aGene Amplification
650 0 4 _aGlioblastoma
_xgenetics
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
_xmethods
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProto-Oncogene Proteins c-met
_xanalysis
700 1 _aNgo-Mai, M
700 1 _aDadone, B
700 1 _aDi Mauro, I
700 1 _aGimet, S
700 1 _aSaada-Bouzid, E
700 1 _aBourg, V
700 1 _aAlmairac, F
700 1 _aFontaine, D
700 1 _aVirolle, T
700 1 _aPedeutour, F
773 0 _tNeuropathology and applied neurobiology
_gvol. 43
_gno. 3
_gp. 252-266
856 4 0 _uhttps://doi.org/10.1111/nan.12320
_zAvailable from publisher's website
999 _c25798949
_d25798949